Kevin Beaumont

Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms

Alex Phipps, Maurice Dickins, Tanya L Hay, 2012, Xenobiotica; the fate of foreign compounds in biological systems.

Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches

Bill J Smith, T. Maurer, K. Beaumont, 2009, Journal of clinical pharmacology.

Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics

Han van de Waterbeemd, H. Waterbeemd, K. Beaumont, 2001 .

Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels

Alex Phipps, Hannah M Jones, Tanya L Hay, 2016, Clinical Pharmacokinetics.

Volume of Distribution in Drug Design.

Li Di, Tristan S. Maurer, T. Maurer, 2015, Journal of medicinal chemistry.

Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

Andrew A. Young, William Vine, T. Rink, 1996 .